BPMC - Blueprint Medicines Corp
IEX Last Trade
95.37
1.760 1.845%
Share volume: 307,148
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$93.61
1.76
1.88%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-16 | 2023-05-04 | 2023-08-02 | 2023-10-26 | 2024-02-15 | 2024-05-02 | 2024-08-01 | |
| Total revenue | 65.977 M | 38.781 M | 63.287 M | 57.570 M | 56.566 M | 71.957 M | 96.116 M | 138.157 M | |
| Cost of revenue | 3.000 M | 4.848 M | 3.175 M | 2.323 M | 2.782 M | 260.000 K | 3.191 M | 7.593 M | |
| Gross profit | 62.977 M | 33.933 M | 60.112 M | 55.247 M | 53.784 M | 71.697 M | 92.925 M | 130.564 M | |
| -46.12% | 77.15% | -8.09% | -2.65% | 33.31% | 29.61% | 40.50% | |||
| Operating expenses | 185.589 M | 181.859 M | 183.023 M | 181.994 M | 180.993 M | 176.851 M | 171.748 M | 173.609 M | |
| Selling general and admin | 57.608 M | 64.020 M | 70.950 M | 71.931 M | 70.741 M | 81.519 M | 83.557 M | 89.339 M | |
| Research and development | 127.981 M | 117.839 M | 112.073 M | 110.063 M | 110.252 M | 95.332 M | 88.191 M | 84.270 M | |
| Total expenses | 188.589 M | 186.707 M | 186.198 M | 184.317 M | 183.775 M | 177.111 M | 174.939 M | 181.202 M | |
| -1.00% | -0.27% | -1.01% | -0.29% | -3.63% | -1.23% | 3.58% | |||
| Operating income | -122.612 M | -147.926 M | -122.911 M | -126.747 M | -127.209 M | -105.154 M | -78.823 M | -43.045 M | |
| Ebit | -122.612 M | -147.926 M | -122.911 M | -126.747 M | -127.209 M | -105.154 M | -78.823 M | -43.045 M | |
| Pretax income | -132.277 M | -157.610 M | -129.040 M | -132.603 M | -133.516 M | -110.857 M | 89.316 M | -49.892 M | |
| 19.15% | -18.13% | 2.76% | 0.69% | -16.97% | -180.57% | -155.86% | |||
| Income tax | 886.000 K | 1.036 M | 520.000 K | 190.000 K | 197.000 K | 61.000 K | 180.000 K | 102.000 K | |
| Net income basic | -133.163 M | -158.646 M | -129.560 M | -132.793 M | -133.713 M | -110.918 M | 89.136 M | -49.994 M | |
| -19.14% | 18.33% | -2.50% | -0.69% | 17.05% | 180.36% | -156.09% | |||
| Net income | -133.163 M | -158.646 M | -129.560 M | -132.793 M | -133.713 M | -110.918 M | 89.136 M | -49.994 M | |
| -19.14% | 18.33% | -2.50% | -0.69% | 17.05% | 180.36% | -156.09% |